Cervical cancer remains a major preventive cancer (oncology) problem in both developed and developing countries, being the third leading cause of cancer mortality among women worldwide. Since the introduction of organized cytological screening programmes among the population, there has been a sharp decrease in the incidence of cervical cancer in many countries. Regardless of this encouraging result, the overall effectiveness of cervical cytologic screening of the cervix, the Papanicolaou smear is still far from optimal. Screening programmes using traditional cytology have successfully reduced the risk of cervical cancer, but new tests such as liquid cytology and human papillomavirus testing could improve screening and accuracy of the data received, and studying the p53 gene, which plays a key role in preventing tumors, could help treat malignancies. The purpose of this report was to study the descriptions of modem minimally invasive methods for determining cervical cancer risks and the possibility of using them in screening oroerammes.